MarketCap
Facebook
X
TelegramQuarterly report 2025-Q3
added 11-06-2025
Nephros Operating Cash Flow 2011-2026 | NEPH
Annual Operating Cash Flow Nephros
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 827 K | -3.23 M | -1.42 M | -6.9 M | -2.28 M | -3.66 M | -77 K | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 827 K | -6.9 M | -2.39 M |
Quarterly Operating Cash Flow Nephros
| 2025-Q3 | 2025-Q2 | 2025-Q1 | 2024-Q4 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| - | - | 322 K | - | - | - | -672 K | - | - | - | 276 K | - | -3.04 M | -2.87 M | -1.8 M | - | -1.08 M | -172 K | -55 K | - | -5.38 M | -3.56 M | -1.84 M | - | -2.64 M | -2.03 M | -697 K | - | -3.13 M | -2.01 M | -669 K | - | -1.87 M | -1.16 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 322 K | -5.38 M | -1.7 M |
Operating Cash Flow of other stocks in the Medical instruments industry
| Issuer | Operating Cash Flow | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Baxter International
BAX
|
845 M | $ 16.47 | -1.08 % | $ 8.45 B |  USA |
 |
Atrion Corporation
ATRI
|
20 K | - | - | $ 810 M | USA |
 |
Alcon
ALC
|
1.34 B | $ 74.46 | -0.25 % | $ 40.4 B |  Schweiz |
 |
The Cooper Companies
COO
|
796 M | $ 69.5 | -1.13 % | $ 13.8 B | USA |
 |
electroCore
ECOR
|
-8.19 M | $ 7.04 | - | $ 59.7 K | USA |
 |
Ekso Bionics Holdings
EKSO
|
-11.8 M | $ 9.6 | -1.54 % | $ 23.3 M | USA |
 |
BioLife Solutions
BLFS
|
8.43 M | $ 19.0 | -1.4 % | $ 875 M | USA |
 |
AtriCure
ATRC
|
57.3 M | $ 28.76 | -1.47 % | $ 1.37 B | USA |
 |
Glaukos Corporation
GKOS
|
-57.8 M | $ 115.08 | -1.41 % | $ 5.57 B | USA |
 |
Haemonetics Corporation
HAE
|
182 M | $ 58.1 | -0.54 % | $ 2.92 B | USA |
 |
Harvard Bioscience
HBIO
|
6.73 M | $ 5.53 | - | $ 245 M | USA |
 |
iRhythm Technologies
IRTC
|
80.9 M | $ 115.36 | -1.59 % | $ 3.69 B | USA |
 |
Repro Med Systems
KRMD
|
462 K | $ 4.25 | -0.23 % | $ 196 M | USA |
 |
Masimo Corporation
MASI
|
196 M | $ 178.34 | -0.08 % | $ 9.51 B | USA |
 |
Microbot Medical
MBOT
|
-13 M | $ 2.32 | -1.91 % | $ 106 M |  Israel |
 |
Milestone Scientific
MLSS
|
-2.92 M | $ 0.29 | - | $ 23.8 M | USA |
 |
Envista Holdings Corporation
NVST
|
276 M | $ 25.51 | -1.22 % | $ 4.29 B | USA |
 |
Pro-Dex
PDEX
|
-1.68 M | $ 48.53 | - | $ 160 M | USA |
 |
ICU Medical
ICUI
|
180 M | $ 121.67 | -1.08 % | $ 3 B | USA |
 |
ResMed
RMD
|
351 M | $ 224.04 | -0.34 % | $ 32.7 B | USA |
 |
InfuSystem Holdings
INFU
|
17.5 M | $ 9.43 | - | $ 195 M | USA |
 |
Retractable Technologies
RVP
|
-7.06 M | $ 0.71 | -0.07 % | $ 21.3 M | USA |
 |
Isoray
ISR
|
-82.5 M | - | 0.03 % | $ 108 M | USA |
 |
Intuitive Surgical
ISRG
|
3.03 B | $ 449.17 | -0.75 % | $ 160 B | USA |
 |
STAAR Surgical Company
STAA
|
-34.2 M | $ 21.44 | 2.29 % | $ 1.06 B | USA |
 |
Stereotaxis
STXS
|
-13.7 M | $ 1.85 | -1.86 % | $ 168 M | USA |
 |
LeMaitre Vascular
LMAT
|
81.3 M | $ 109.83 | 0.61 % | $ 2.49 B | USA |
 |
Merit Medical Systems
MMSI
|
297 M | $ 66.72 | -1.61 % | $ 3.95 B | USA |
 |
Utah Medical Products
UTMD
|
14.7 M | $ 63.75 | 1.3 % | $ 207 M | USA |
 |
Predictive Oncology
POAI
|
-12.4 M | - | - | $ 31.1 M | USA |
 |
Pulse Biosciences
PLSE
|
-54.1 M | $ 21.68 | -5.49 % | $ 1.46 B | USA |
 |
West Pharmaceutical Services
WST
|
755 M | $ 258.0 | 0.4 % | $ 18.7 B | USA |
 |
DENTSPLY SIRONA
XRAY
|
235 M | $ 11.45 | -1.63 % | $ 2.28 B | USA |
 |
NeuroMetrix
NURO
|
-7.13 M | - | 5.05 % | $ 9.02 M | USA |
 |
STERIS plc
STE
|
1.15 B | $ 219.18 | -0.37 % | $ 21.6 B | USA |
 |
AngioDynamics
ANGO
|
-10.1 M | $ 9.51 | -3.35 % | $ 389 M | USA |
 |
Becton, Dickinson and Company
BDX
|
3.33 B | $ 154.32 | -0.59 % | $ 44.4 B | USA |
 |
OraSure Technologies
OSUR
|
-49 M | $ 3.05 | -1.14 % | $ 224 M | USA |
 |
Repligen Corporation
RGEN
|
114 M | $ 116.46 | -0.42 % | $ 6.49 M | USA |